The talks highlighted progress in our hybridoma 
sequencing initiative, to secure important antibody collections globally and development of new reagents. We also outlined the continued expansion of our recombinant antibody capabilities, supporting various antibody discovery and vaccine development campaigns across livestock species.
In addition, we shared an update to revamp the Immunological Toolbox website to improve community engagement, streamline access to reagents, and enhance mechanisms for sharing resources with the wider community (see the abstract here).
No comments available